Alexander Monto, MD

Gastroenterologist

Dr. Alexander Monto is a viral hepatitis expert with a special interest in hepatitis B and hepatitis C and antiviral therapies for these conditions. Monto currently serves as the associate director of the San Francisco Veterans Affairs Hepatitis C Resource Center at San Francisco Veterans Hospital. In addition to caring for patients, Monto also is involved in clinical trials investigating new drugs for viral hepatitis. His previous research on hepatitis has been widely published in medical journals and he has been invited to lecture on his work at various medical conferences. Monto also serves as the medical editor of the National Veterans Affairs Hepatitis C Web site and is a member of numerous professional organizations, such as the American Association for the Study of Liver Disease (AASLD) and American Gastroenterology Association.

Monto earned his medical degree from Columbia University, College of Physicians and Surgeons, New York and completed residencies in internal medicine at Columbia Presbyterian Medical Center, New York and Massachusetts General Hospital, Boston. He then went on to complete a fellowship in gastroenterology at UCSF before joining the faculty in 2001, where he holds the position of professor of medicine.

Conditions & Treatments

Academic Title

Professor

More about Alexander Monto

Additional Languages

Spanish

Education

Columbia College of Physicians and Surgeons 1995

Residencies

Massachusetts General Hospital, Internal Medicine 1995

Fellowships

UCSF Medical Center, Gastroenterology 1995

Selected Research and Publications

  1. Méndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. J Immunol. 2018 Feb 01; 200(3):1124-1132.
  2. Lee JY, Huo EJ, Weinstein S, Santos C, Monto A, Corvera CU, Yee J, Hope TA. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma. Abdom Radiol (NY). 2017 Oct 10.
  3. Hope TA, Aslam R, Weinstein S, Yeh BM, Corvera CU, Monto A, Yee J. Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography. J Comput Assist Tomogr. 2017 May/Jun; 41(3):376-381.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.